ProMIS advances Alzheimer's drug to final dose level in clinical trial

Related
FuelCell Energy Non-GAAP EPS of -$0.95 beats by $0.68, reven...
6 minutes ago
0
TotalEnergies, South Korea's KOGAS sign 10-year LNG supply d...
7 minutes ago
0
China’s rapid submarine advances spark undersea arms race in...
8 minutes ago
0
Nano Dimension stock jumps on strategic review, names David ...
9 minutes ago
0
Arista Networks appoints co-founder Duda as President
11 minutes ago
0
Serve Robotics enhances its tech stack through the acquisiti...
12 minutes ago
0
Talen Energy upsizes share buyback program by $1.005B
16 minutes ago
0
IonQ in focus as company announces analyst day
22 minutes ago
0
Mobilicom’s U.S. drone manufacturer customer increases recen...
24 minutes ago
0
Phillips 66 to buy remaining stake in WRB Refining from Ceno...
24 minutes ago
0
Cognyte Software tops Q2 estimates; raises FY outlook
25 minutes ago
0
Nike and Lowe's are added to Jefferies' Franchise Picks List...
26 minutes ago
0
Companies are spending so much on AI they’re cutting share b...
28 minutes ago
0
Karisma Kapoor’s children move Delhi HC over late father Sun...
30 minutes ago
0
Sailfish Royalty declares $0.0125 dividend
30 minutes ago
0
Amgen, Kyowa Kirin announce long-term Phase 3 data for eczem...
31 minutes ago
0
SailPoint tops Q2 estimates; initiates Q3 and updates FY out...
32 minutes ago
0
Buckle declares $0.35 dividend
34 minutes ago
0
Jobs revision today could show more labor market weakness
34 minutes ago
0
Fighting Maroons open UAAP title defense against host UST
35 minutes ago
0
Trending
Popular
© FBT Company 2025. All rights are reserved